This study demonstrates enhanced bioactive metabolites in dark-pigmented ranunculus asiaticus flowers, suggesting new therapeutic uses.
This study investigates the phytochemical and pharmacological profiles of dark-pigmented versus light-pigmented Ranunculus asiaticus flowers, testing the hypothesis that floral pigmentation intensity predicts bioactive metabolite richness. Dark flowers exhibited significantly elevated levels of flavonoids (e.g., Burgundy: 33.1 mg/g DW), tannins, saponins, and steroids—absent in light morphotypes—validating the co-pigmentation defense hypothesis. Quantitative analyses revealed intra-varietal heterogeneity among dark phenotypes, with Burgundy flowers showing the highest polyphenol content (52.5 mg/g DW). GC-MS identified key bioactives (e.g., β-caryophyllene: 12.1%, palmitic acid: 18.2%, β-sitosterol: 11.6%), while HPLC quantified dominant flavonoid glycosides (quercetin-3-O-glucoside: 12.8 mg/g). The extract demonstrated potent concentration-dependent anti-inflammatory activity (92.7% membrane stabilization at 800 μg/mL; IC₅₀: 135.2 μg/mL), strong antioxidant capacity (DPPH: 92.5% scavenging at 400 μg/mL), and broad-spectrum antimicrobial effects (against S. aureus: MIC = 0.52 mg/mL). These findings highlight dark-pigmented R. asiaticus as an underexplored reservoir of therapeutic compounds, with potential applications in nutraceutical, pharmaceutical, and dermatological formulations aimed at combating oxidative stress and inflammatory skin conditions.
No takes yet. Share an insight, caveat, or question.
Faraj Ahmad Abuilaiwi (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: